Navigation Links
Apexus Announces HRSA's 340B Prime Vendor Contract Renewal
Date:9/11/2012

IRVING, Texas, Sept. 11, 2012 /PRNewswire/ -- The Health Resources and Services Administration (HRSA) has elected to continue its relationship with Apexus by renewing for another year the agreement making Apexus the government's prime vendor for the 340B program. HRSA chose to exercise this one year renewal following a careful audit and review of Apexus' proven ability to maintain, coordinate and advance the 340B Prime Vendor Program.

The agreement between Apexus and HRSA, effective September 10, 2009, has a term of two years, with three one-year renewal options. HRSA exercises the one-year renewal options each year after reviewing Apexus's abilities and performance against other potential vendors.

"We are pleased to continue our relationship with HRSA," said Christopher Hatwig, Vice President at Apexus. "As the government's prime vendor for the 340B program, we believe the program is an essential federal program, and we are committed to providing value to the eligible organizations we serve. Since our partnership began, in addition to regulatory discounts on covered outpatient drugs, the Program has added numerous value-added products and services."

The 340B Drug Pricing Program is a Federal program that requires drug manufacturers to provide outpatient drugs to eligible safety-net health organizations at a reduced price to ensure patient access to medications, which is a key component of successful clinical pharmacy services and providing a high-quality continuum of care. As the contractor to the 340B Prime Vendor, Apexus is responsible for negotiating pharmaceutical pricing below the 340B price as well as improving access to affordable medications by establishing a distribution network for pharmaceuticals to covered entities.

"We believe the 340B Drug Pricing Program helps improve access to affordable medications for covered entities and underserved patient groups," adds Hatwig. "Without the Program, we believe many of the natio
'/>"/>

SOURCE Apexus
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NuAire Announces New In-VitroCell Energy Saver CO2 Incubators
2. Thoratec Announces Presentations At Upcoming Investor Conferences
3. Hemp, Inc. Division Marijuana Inc. Announces Medical Grow Tour Venue In Portland, Oregon
4. MD+DI Announces Wireless Connectivity in Medical Devices EAST Conference in Boston, MA
5. Neurotech Reports Announces New Conference Dedicated to Consumer Applications of Neurotechnology
6. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
7. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
8. CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development
9. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
10. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
11. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... GRAND RAPIDS, Mich. , Jan. 15, 2014 As ... of the flu virus, select Meijer pharmacies in ... and strep throat to eligible patients, enabling Meijer pharmacists to ... under strict protocol set by a physician participating in the ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces ... condition to the announced tender offer for all of the outstanding ... result of the waiver, the transaction is no longer conditional on ... January 24, 2014 following the currently scheduled expiration time, subject to ...
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... /PRNewswire/ -- PRA International, a leading Clinical Research ... during the 8th Annual Partnerships in Clinical Trials 2009 to ... Trade Centre in Rotterdam, The Netherlands. PRA operational and ... exhibiting at booth number 32. , On 4 November, PRA,s ...
... Shire plc (LSE: SHP, NASDAQ:,SHPGY) the global specialty biopharmaceutical company, announces results for,the three months to September 30, 2009. , , ... ... sales ... Product sales from core products(2) $532 ...
Cached Medicine Technology:PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 2Shire Continues to Deliver Excellent Growth From Core Products 2Shire Continues to Deliver Excellent Growth From Core Products 3Shire Continues to Deliver Excellent Growth From Core Products 4Shire Continues to Deliver Excellent Growth From Core Products 5Shire Continues to Deliver Excellent Growth From Core Products 6Shire Continues to Deliver Excellent Growth From Core Products 7Shire Continues to Deliver Excellent Growth From Core Products 8Shire Continues to Deliver Excellent Growth From Core Products 9Shire Continues to Deliver Excellent Growth From Core Products 10Shire Continues to Deliver Excellent Growth From Core Products 11Shire Continues to Deliver Excellent Growth From Core Products 12Shire Continues to Deliver Excellent Growth From Core Products 13Shire Continues to Deliver Excellent Growth From Core Products 14Shire Continues to Deliver Excellent Growth From Core Products 15Shire Continues to Deliver Excellent Growth From Core Products 16Shire Continues to Deliver Excellent Growth From Core Products 17Shire Continues to Deliver Excellent Growth From Core Products 18Shire Continues to Deliver Excellent Growth From Core Products 19Shire Continues to Deliver Excellent Growth From Core Products 20Shire Continues to Deliver Excellent Growth From Core Products 21Shire Continues to Deliver Excellent Growth From Core Products 22Shire Continues to Deliver Excellent Growth From Core Products 23Shire Continues to Deliver Excellent Growth From Core Products 24Shire Continues to Deliver Excellent Growth From Core Products 25Shire Continues to Deliver Excellent Growth From Core Products 26Shire Continues to Deliver Excellent Growth From Core Products 27Shire Continues to Deliver Excellent Growth From Core Products 28Shire Continues to Deliver Excellent Growth From Core Products 29Shire Continues to Deliver Excellent Growth From Core Products 30Shire Continues to Deliver Excellent Growth From Core Products 31Shire Continues to Deliver Excellent Growth From Core Products 32Shire Continues to Deliver Excellent Growth From Core Products 33
(Date:4/18/2014)... new article published online in The Gerontologist ... religious music is associated with a decrease in anxiety ... sense of control over their lives. In particular, listening ... anxiety about death and an increase in sense of ... whites, women and men, and individuals of both low- ...
(Date:4/18/2014)... Two Simon Fraser University psychologists have made a ... treatment of attention-deficit disorders. , This discovery opens ... may hinder or suppress a specific brain activity ... prevent distraction. , The Journal of Neuroscience ... discovery by John McDonald, an associate professor of ...
(Date:4/17/2014)... show signs of chronic inflammation in non-cancerous prostate tissue ... prostate cancer than those with no inflammation, according to ... the Johns Hopkins Kimmel Cancer Center. , The link ... men with so-called high-grade prostate cancer those with ... the presence of the most aggressive and rapidly growing ...
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary ... Paul Kenis in the Institute of Genomic Biology ... Illinois Urbana-Champaign describe their recent work on subcellular ... of cell functions including energy metabolism, signaling, and ... regulating normal cellular behavior, redox status has been ...
(Date:4/17/2014)... has created a new technology for modifying human ... the body and selectively target cancer and other ... that monitor and modify human physiology is a ... existing technology enabled bioengineers to build such devices ... in a customized fashion. , "The project addressed ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2
... Citizens by Enhancing Their ... Own Plans, ... help them prepare for one of the most daunting public,health emergencies: an ... Policy (CIDRAP) at,the University of Minnesota and the Pew Center on the ...
... Organization Urges Consumers to ... Beware!, ... Society of Cosmetic Dermatology and Aesthetic,Surgery (ASCDAS), responded to the recent decision ... of Healing Arts to ban the,liposuction treatment, Lipodissolve. "This procedure is still ...
... or circulating tumour cells (CTCs), are known to be associated ... Now, for the first time, a group of scientists have ... chemotherapy treatment and hence may be able to identify those ... such treatment in future. , Dr. Julia Jckstock, from the ...
... Driven by Launches, of Disease-Modifying Therapies, According to a New ... ... Resources, WALTHAM, Mass., Sept. 24 Decision Resources, one of ... that by 2016 Genentech/Roche,s Lucentis and Eli,Lilly,s ruboxistaurin will drive the ...
... DUBLIN, Ohio, Sept. 24 Cardinal Health, a,global provider ... of health care, today announced President and Chief Executive,Officer ... effective Nov. 8,following the company,s 2007 annual shareholder meeting. ... who plans to retire,at the end of the company,s ...
... University of Warwick, and University College London, have found that ... death from cardiovascular disease. However they have also found that ... double the risk of death. , In research to be ... Society, Professor Francesco Cappuccio from the University of Warwicks Warwick ...
Cached Medicine News:Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 2Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 3Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 4Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 5Health News:Lipodissolve - Is it Safe??? 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 3Health News:Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 3Health News:Researchers say lack of sleep doubles risk of death... but so can too much sleep 2
... orthosis is designed for the management ... diaphyseal fractures. The lightweight anatomical design ... compression for optimal control of humeral ... both the shoulder and elbow joints. ...
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion...
... RCAI Plantar Fasciitis Night Splint is indicated ... Achilles tendonitis. It is economical and easy ... assist straps for controlled dorsiflexion, limiting nightly ... and Achilles tendon. This feature permits flexibility ...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon...
Medicine Products: